AKT1 and cancer: Recent evidence suggests that SREBPs are activated by phosphoinositide 3-kinase (PI3K) and Akt, both of which are considered to be mainly implicated in cell survival signalling pathways with many implications in most multifactorial diseases such as cancer and diabetes [24].